Last reviewed · How we verify

NCT03245216: FAST-PD

Facilitating Motor Skill Learning in Parkinson's Disease

Completed NA Last updated 24 October 2018
What this trial tests

NA trial testing aerobic exercise in Parkinson Disease in 28 participants. Completed in 30 September 2018.

Timeline
1 March 2017
Primary endpoint
31 May 2018
30 September 2018

Quick facts

Lead sponsorUniversity of Erlangen-Nürnberg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 March 2017
Primary completion31 May 2018
Estimated completion30 September 2018
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Erlangen-Nürnberg

Who can join

18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to assess the effects of aerobic exercise on motor learning in Parkinson patients. Specifically, the investigators examine whether a single bout of moderate intensity aerobic exercise, performed immediately before task practice, facilitates the acquisition and retention of a motor skill. In a cross-over design, participants will be randomly allocated to either the intervention group (aerobic exercise before motor learning) or control group (rest before motor learning).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Single Bout of Aerobic Exercise Improves Motor Skill Consolidation in Parkinson's Disease.
    Steib S, Wanner P, Adler W, Winkler J, et al · · 2018 · cited 36× · PMID 30405397 · DOI 10.3389/fnagi.2018.00328

Verify or expand the search:

Other trials of aerobic exercise

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of Erlangen-Nürnberg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03245216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing